Medicare AdvantageCoverageMedium impact
MA07.016c, Intravenous Chelation Therapy
Independence Blue Cross·Cardiology, Nephrology, Endocrinology +2 more·Medical Policy
Effective date
Aug 6, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA07.016c for Intravenous Chelation Therapy has been reissued with an effective date of August 6, 2025. This is a policy update that affects coverage or billing requirements for intravenous chelation therapy services under Medicare Advantage plans.
Action Required
By August 6, 2025: Billing team must review the updated MA07.016c policy for Intravenous Chelation Therapy to understand any changes to coverage criteria, prior authorization requirements, or billing guidelines. Access the full policy at the provided URL to identify specific billing code changes or documentation requirements that may affect claim processing.